JP2022500398A5 - - Google Patents

Info

Publication number
JP2022500398A5
JP2022500398A5 JP2021513789A JP2021513789A JP2022500398A5 JP 2022500398 A5 JP2022500398 A5 JP 2022500398A5 JP 2021513789 A JP2021513789 A JP 2021513789A JP 2021513789 A JP2021513789 A JP 2021513789A JP 2022500398 A5 JP2022500398 A5 JP 2022500398A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
therapeutic agent
lipid
anesthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021513789A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022500398A (ja
JP7482487B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/050767 external-priority patent/WO2020056102A1/en
Publication of JP2022500398A publication Critical patent/JP2022500398A/ja
Publication of JP2022500398A5 publication Critical patent/JP2022500398A5/ja
Application granted granted Critical
Publication of JP7482487B2 publication Critical patent/JP7482487B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021513789A 2018-09-13 2019-09-12 鎮静薬を含む徐放性医薬組成物およびその使用 Active JP7482487B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862730713P 2018-09-13 2018-09-13
US62/730,713 2018-09-13
PCT/US2019/050767 WO2020056102A1 (en) 2018-09-13 2019-09-12 Sustained-release pharmaceutical compositions comprising of a sedative drug and uses thereof

Publications (3)

Publication Number Publication Date
JP2022500398A JP2022500398A (ja) 2022-01-04
JP2022500398A5 true JP2022500398A5 (enExample) 2022-09-09
JP7482487B2 JP7482487B2 (ja) 2024-05-14

Family

ID=69777824

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021513789A Active JP7482487B2 (ja) 2018-09-13 2019-09-12 鎮静薬を含む徐放性医薬組成物およびその使用

Country Status (6)

Country Link
US (1) US20220054455A1 (enExample)
EP (1) EP3849532A4 (enExample)
JP (1) JP7482487B2 (enExample)
CN (1) CN112654348A (enExample)
TW (1) TWI755629B (enExample)
WO (1) WO2020056102A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12472158B2 (en) * 2019-02-27 2025-11-18 Vanderbilt University Methods of treating trigeminal nerve pain
WO2021211575A1 (en) * 2020-04-13 2021-10-21 The Regents Of The Univefisity Of California Compositions comprising propofol, ketamine, and non-opioid analgesic, and methods of use
CN116688137B (zh) * 2023-07-21 2024-05-14 中国医学科学院北京协和医院 一种基于核壳结构的药物组合物及应用
CN118986892A (zh) * 2024-09-29 2024-11-22 济南大学 一种醋酸阿比特龙胆盐脂质体组合物及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9700850A (es) * 1995-06-09 1997-09-30 Euro Celtique Sa Formulaciones y metodos para proporcionar anestesia local prolongada.
IL140892A0 (en) * 1998-08-12 2002-02-10 Yissum Res Dev Co Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient
AU2003298738A1 (en) * 2002-11-26 2004-06-18 Su-Ming Chiang Liposomal formulations
WO2006027787A1 (en) * 2004-09-09 2006-03-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposomal compositions of glucocorticoid and glucocorticoid derivatives
CN101756902B (zh) * 2008-12-23 2011-10-05 上海医药工业研究院 一种可乐定多囊脂质体及其制备方法
BR112013016365A2 (pt) * 2010-12-27 2018-06-26 Terumo Corp composição de lipossoma e processo para produção do mesmo
US20130096170A1 (en) * 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
AU2013256008B2 (en) * 2012-05-04 2016-02-25 The Johns Hopkins University Lipid-based drug carriers for rapid penetration through mucus linings
WO2014121211A2 (en) * 2013-02-01 2014-08-07 Zoneone Pharma, Inc. Remote loading of sparingly water-soluble drugs into liposomes
EP2968145A1 (en) * 2013-03-13 2016-01-20 Mallinckrodt LLC Modified docetaxel liposome formulations
ES2777223T3 (es) * 2013-03-15 2020-08-04 Taiwan Liposome Co Ltd Composición de liposoma para liberación controlada de fármaco
US9895313B2 (en) * 2015-03-03 2018-02-20 Cureport, Inc. Combination liposomal pharmaceutical formulations
WO2016191547A1 (en) * 2015-05-26 2016-12-01 Comfort Care For Animals Llc Liposome loading
US11344498B2 (en) * 2015-10-08 2022-05-31 The Children's Medical Center Corporation Compositions and methods for on-demand high-efficiency triggerable anesthesia
MX2018008507A (es) * 2016-01-11 2019-07-04 Merrimack Pharmaceuticals Inc Inhibición de proteína relacionada con ataxia telangiectasia y rad3 (atr).
EP3829539A4 (en) * 2018-08-02 2022-05-04 Taiwan Liposome Company, Ltd. DELAYED RELEASE COMPOSITIONS WITH A THERAPEUTIC AGENT FOR THE TREATMENT OF DEPRESSION OR ANXIETY AND USES THEREOF
US12285524B2 (en) * 2018-08-08 2025-04-29 Taiwan Liposome Co., Ltd. Sustained-release pharmaceutical compositions comprising an antipsychotic drug and uses thereof

Similar Documents

Publication Publication Date Title
JP2022500398A5 (enExample)
US9205052B2 (en) Sustained-release liposomal anesthetic compositions
JP2017515913A5 (enExample)
RU2014120216A (ru) Комбинационные липосомальные композиции для лечения рака
JP2013526545A5 (enExample)
HRP20191805T1 (hr) Postupci za liječenje netuberkuloznih mikobakterijskih infekcija pluća
CA2739822A1 (en) Liposomal systems comprising sphingomyelin
FI3821887T3 (fi) Mitoksantroni liposomin käyttö ei-hodgkinin lymfooman hoitoon
EP2968146B1 (en) Controlled drug release liposome composition
JPS5823619A (ja) リウマチ様関節炎の治療薬
EP2498792B1 (en) Compositions comprising phospholipid carriers for the treatment of otitis externa
TWI755629B (zh) 含鎮靜藥物之緩釋藥物組合物及其用途
TWI776076B (zh) 含有治療失智症之治療劑的緩釋藥物組合物及其用途
JP2019516693A5 (enExample)
TWI767133B (zh) 含有治療憂鬱症或焦慮症之治療劑的緩釋組合物及其用途
US20190216932A1 (en) Controlled drug release liposome compositions and methods thereof
WO2013146386A1 (ja) 局所麻酔薬持続性徐放製剤
Viscusi Liposomal drug delivery for postoperative pain management
WO2014209246A1 (en) Design of terbinafine hydrochloride loaded liposome included pullulan film system for ungual treatment of onychomycosis
JP2022505378A5 (enExample)
TW202114668A (zh) 緩釋脂質組合物及其製備方法
TWI850208B (zh) 緩釋型翠普登組成物及其經皮下或類似途徑使用之方法
HK40046574A (en) Sustained-release pharmaceutical compositions comprising of a sedative drug and uses thereof
WO2025230917A1 (en) Methods for treating systemic sclerosis and frost bite by inhalation therapy
RU2021132189A (ru) Фармацевтическая композиция слабокислотного лекарственного средства и способы применения